FdaApplication

BLA 103663

Back to search

Identifiers

Properties

PropertyValue
applicant_nameKadmon Pharmaceuticals LLC
application_typeBLA
approval_date1997-10-06

Products (1)

ProductActive ingredientStrengthDosage form
INFERGEN—9MCG/0.3ML (30MCG/ML)Injection

1 product